Fight for Sight fundraiser honoured at the Lloyd's Market Charity Awards

21 December 17

written by:

Press Office

(more articles)

Maddie, Chris and Kirsty Perkins at the awards in December 2017

Earlier this month the Lloyd’s Charities Trust honoured a Fight for Sight fundraiser with a £2,000 award in recognition of her fundraising and voluntary work.

Kirsty Perkins, who works for Chubb Insurance, has supported Fight for Sight for a number of years and this £2,000 will be used to fund more research into Stargardt macular dystrophy, a rare inherited eye condition. Kirsty’s daughter, Maddie, lives with Stargardt’s and has inspired Kirsty and many of her friends and family to fundraise for research into the condition. Stargardt’s is currently untreatable so the research is vital.

Kirsty and Maddie, from Kingston in Surrey, have helped to raise more than £38,000 for Fight for Sight this year alone. The black tie “eye ball” fundraiser, held in June, raised more than £36,000 for the charity. This fabulous total, along with the award from the Lloyd’s Charities Trust, will be added to as family and friends participate in the London Marathon in April 2018.

The Lloyd’s Charities Trust donates to 30 charities on behalf of individuals in the insurance market every year to recognise voluntary work. This year 64 applications were received for the awards, which were presented by Chris Harman, Chairman of the Trust and Partner at JLT. Commenting on the awards, he said: “The trustees are always amazed by the amount of effort that individuals in the market give to good causes - from showing great resolve in the face of adversity, to organising black tie events, chairing charities and running multiple marathons. The people of the Lloyd’s market make a fantastic impact and we are delighted to be able to recognise that through the Lloyd’s Market Charity Awards.”

Michele Acton, Chief Executive of Fight for Sight, said: “On behalf of Fight for Sight I would like to thank the Lloyd’s Charities Trust for this donation. This will allow us to continue supporting the research necessary to tackle Stargardt’s, a currently untreatable condition. Only by investing in research will we be able to deliver breakthroughs to address sight loss.”